Publications by authors named "Enjun Zhang"

Claim this Profile
N
Novel PI3Kδ inhibitor exerts antitumor activity in Burkitt lymphoma by inducing ROS-dependent apoptosis.
Enjun Zhang, Jun Lu, Liying Liu, Lunming Liu, Hongtao Hu

Med Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer.
Ya-Nan Zheng, Si-Yue Lou, Jun Lu, Fan-Li Zheng, Yong-Mei Tang, En-Jun Zhang

Cell Death Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas.
Si-Yue Lou, Fan-Li Zheng, Yong-Mei Tang, Ya-Nan Zheng, Jun Lu, En-Jun Zhang

Life Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis